Cantor Fitzgerald Reiterates Neutral Rating on Centene (CNC)

Cantor Fitzgerald analyst Sarah James reiterated a Neutral rating and $38.00 price target on Centene (NYSE: CNC).

The analyst commented, "3Q25 Medicaid enrollment files exemplify the role state-specific exposure plays into '26, ELV & CNC see the largest state-specific shift despite 0% change overall. We view our compilation of state-reported Medicaid enrollment as key in '26 as we anticipate Medicaid commentary may vary from payor to payor significantly. In our view, the inconsistency among the group will be driven by state-specific approaches to Medicaid budget cuts & timing of rolling out work requirements."

For an analyst ratings summary and ratings history on Centene click here. For more ratings news on Centene click here.

Shares of Centene closed at $35.68 yesterday.

You May Also Be Interested In

• 5.5 magnitude earthquake strikes Northern California - EMSC
• Samsara launches 360 camera for forklifts, tugs, and equipment
• Crude Inventory Fell 6.1 Million Barrels Last Week, Says EIA